Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model

The systemic delivery of doxorubicin (DOX) to treat osteosarcoma requires an adequate drug concentration to be effective, but in doing so, it raises the risk of increasing organ off-target toxicity and developing drug resistance. Herein, this study reveals a multiple therapeutic nanocarrier delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Suphalak Khamruang, Saelim, Boonyisa, Taweesap, Maneerat, Pachana, Verachai, Panrak, Yada, Makchuchit, Naritsara, Jaroenpakdee, Passara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565722/
https://www.ncbi.nlm.nih.gov/pubmed/36234645
http://dx.doi.org/10.3390/nano12193517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565722/
https://www.ncbi.nlm.nih.gov/pubmed/36234645
http://dx.doi.org/10.3390/nano12193517

Ejemplares similares